[Toxicity of derivatives of 2-(beta-dialkylaminoethyl)pyridine].
D000311:Adrenal Glands / Q000032:analysis; D000818:Animals; D001237:Asphyxia / Q000139:chemically induced; D001923:Brain Chemistry / Q000187:drug effects; D001927:Brain Diseases / Q000139:chemically induced; D001986:Bronchial Spasm / Q000139:chemically induced; D002318:Cardiovascular Diseases / Q000139:chemically induced; D056486:Chemical and Drug Induced Liver Injury; D005260:Female; D006003:Glycogen / Q000032:analysis; D007274:Injections, Intraperitoneal; D007279:Injections, Subcutaneous; D007674:Kidney Diseases / Q000139:chemically induced; D008055:Lipids / Q000032:analysis; D008099:Liver / Q000032:analysis; D008112:Liver Glycogen / Q000032:analysis; D008168:Lung / Q000187:drug effects; D008297:Male; D051379:Mice; D009206:Myocardium / Q000032:analysis; D011725:Pyridines / Q000008:administration & dosage* / Q000633:toxicity*; D012313:RNA / Q000032:analysis; D051381:Rats; D013158:Splenic Diseases / Q000139:chemically induced
D008055:Lipids; D008112:Liver Glycogen; D011725:Pyridines; D012313:RNA; D006003:Glycogen
Toksichnost' proizvodnykh 2-(beta-dialkilamino)piridina.